Congratulations to our Digital RESI “Europe” Innovation Challenge Winners!

26 Mar

By Claire Jeong, Vice President of Investor Research, Asia BD, LSN

claireOur 3-day digital RESI “Europe” event came to an end yesterday, and we are very excited to announce the Top 3 Winners of the Innovation Challenge. This was a very special Innovation Challenge for the RESI team as all of the poster presentations were held in digital format, with each finalist company having a dedicated page where you could view their poster, short pitch, and other supplementary materials that the companies made available for viewing.

We will keep our RESI Europe “live agenda” page open to the public for another month, so if you have not had the chance already, please visit Digital RESI Europe Live Agenda to see our virtual exhibit of some amazing technologies across therapeutics, medical devices, diagnostics, and digital health!

We would like to thank every Innovation Challenge company for quickly adapting to our digital transition, and we hope that all companies were able to make the most out of the digitally presented Innovation Challenge.

Congratulations to the Top 3 winners, and thank you all for casting your votes!

First Place: Cerebriu A/S

Click Here to Check Out Cerebriu’s Digital Poster

Cerebriu is dedicated to improving workflow efficiency, quality and patient outcomes in diagnostic imaging.

Our software solution Cerebriu Apollo achieves this by automating image acquisition protocols and triage during MRI brain acquisition providing decision support at key stages of the diagnostic process. We offer workflow efficiency gains that result in improved productivity, better use of resources, and prioritization of the patients who need it most.

Initial focus is brain, namely tumors, haemorrhage and infarcts. Future roadmap expands to additional pathologies, body parts and advanced integration with hospital systems.

Second Place: MOWOOT

Click Here to Check Out MOWOOT’s Digital Poster

MOWOOT is a growth stage medical device company targeting intestinal transit disorders with a purely physical, non-drug, non-invasive solution.

MOWOOT offers a CE certified (Med.Dev. class IIa), IP protected, clinically validated and award-winning technology: the first Intermittent Colonic Exo-peristalsis (ICE) device on the market handling a large unmet need for patients with Neurogenic-Bowel-Disorders (NBD), Idiopathic Chronic Constipation (ICC) and Opioid-Induced-Constipation (OIC).

The Global Market for the indication “chronic constipation” alone has an annual worth of US$ 12.58 bn, with a healthy CAGR of 7.1%, estimated to reach US$ 22,93 bn by 2025.

Third Place: Injeq Oy

Click Here to Check Out Injeq’s Digital Poster

IQ-Needle is a hypodermic needle which can tell where its tip is. This makes demanding blind punctures, such as spinal tap, much easier and safer for the patient. Technology is based on measuring the impedance of the tissue the tip is touching using proprietary stylet design, allowing the needle bosy and styulet to be used as electronic measurement probes. IQ-Needle and Analyzer are in pre-production as we are finalizing clinical trials and starting the CE certification process with TÜV SÜD in Germany.

LSN Pivots Again: To Accommodate Early-Stage Life Science Fundraising CEOs and Investment Partners

26 Mar

By Gregory Mannix, Chief Conference Officer, Vice President International Business Development, LSN

After a record breaking Digital RESI Conference in March, replacing the RESI Europe 2020 on-site event, LSN now announces one new Digital RESI, 2-day, dedicated partnering event, taking place April 29th and 30th,  a new Digital RESI event June 8th-10th, replacing on-site RESI, San Diego and, last but not least, Boston RESI On-site September 21st at the Boston Marriott Copley Place.

The feedback from LSN’s Investment, partnering and entrepreneurial networks made this move obvious, as new fresh alternatives are needed to keep the bench to bedside technology assets flowing in the right direction. The main issue with raising early stage capital is that it is a numbers game and entrepreneurs need to regularly work their pipeline of investment partners. The fact that Digital RESI proved that the virtual model works means that LSN can now offer one dedicated Digital partnering event in April, a Digital RESI three day event in June plus the on-site, Boston RESI in September. Interested investors can contact us for a complimentary pass to all of these events here:

LSN is also offering a discounted packaged deal which is a much needed solution for engaging with global investment partners on regular basis. LSN will also be giving a free copy of the Life Science Entrepreneurs Fundraising Manifesto with each registration.  This book outlines how to prepare your branding and messaging, how to set up a CRM for keeping track of your Global Target List of investment partners and goes into the detail of both phone and email canvassing for setting up meetings.  LSN is convinced that this package will be a game changer in these coming months for all the global fundraising entrepreneur community.

Digital RESI in Numbers

26 Mar

By Karen Deyo, Senior Investor Research Analyst, LSN

Digital RESI was an idea that arose under unusual circumstances, to say the least. As RESI drew near, we were overwhelmed with the positive responses we received to the change, and our attempt to move forward with an alternative to the traditional on-site conference. Now that the first Digital RESI is behind us, what do the numbers say?

With about 550 attendees, we saw over 1200 meetings taking place over the 3 days of partnering. Below you can find the breakdown of attendees and meetings. With 70% of the meetings taking place between companies and investors, this goes to show that investors are still hungry for good investments, despite the current environment. And while coordinating across time zones is extremely difficult, over 85% of the meetings took place as scheduled.

The proof is in the numbers – digital conferences are providing a way for startups and investors to meet and form relationships with a virtual one-on-one meeting. Make sure to check out the future digital events we will be holding to help make it through the coming months!

Important Information about Digital RESI Partnering

22 Mar

By Karen Deyo, Senior Investor Research Analyst, LSN

Thank you for participating in the first-ever Digital RESI. We want to make sure that this event is a success for you, and the following information will help you use the partnering platform to best advantage in this virtual conference.

First, please note that all currently scheduled meetings take place in Paris local time (CET). Please be aware that you can block off time slots so that you are not getting scheduled by the system at a time that is inconvenient due to your local time zone. The good news is, if you have accepted some meetings, you can reschedule your meetings to a more convenient time.

This is one of the challenges in going from a physical to a global digital format and LSN wants to make sure that all the meetings you book will work for both parties. Also, LSN does recommend making sure you have exchanged phone numbers with the other person, so that if something does happen you can just call the person directly.

Depending on your location, this would mean that the partnering slots take place at:

San Francisco (PST) 12AM-12PM
New York (EST) 3AM-3PM
Paris (CET) 8AM-8PM
Shanghai 3PM-3AM

Digital RESI is giving us an opportunity to continue with LSN’s mission to connect early stage companies with investors and strategic partners who are a fit for them, and we urge all of you to take full advantage of the partnering platform by accepting meetings over the three days of partnering. Virtual partnering meetings will start in 5 short days – make sure to fill your schedule!

How Does RESI Virtual Partnering Work?

19 Mar

By Bryanna Allison, Business Development Manager, LSN

In anticipation of RESI’s Virtual Partnering platform going live next week, many have asked us how the system will work. The core of RESI Partnering remains unchanged, and we now have the added functionality of a virtual meeting platform. The following video demonstration shows how to navigate the new features while still taking advantage of everything that makes RESI Partnering special. Make sure to check out the video, so you are ready for 3 days of partnering!

The Show Must Go On

19 Mar


– An interview with Big4Bio & Dennis Ford, Founder & CEO of Life Science Nation and Creator of the RESI Conference Series

Dennis Ford

Big4Bio: Please tell Big4Bio how you decided to make RESI Digital? 

Dennis Ford (DF): “The show must go on!” has been the mantra at LSN since the COVID-19 troubles literally changed the daily landscape of the entire planet. LSN really didn’t have much of a choice when deciding to take the physical RESI Europe Paris conference and making it DIGITAL. We specialize in getting early satge life science products funded so that they can be developed and make it to market.  The “bench to bedside” journey is under a vast transition and LSN hopes we can do our best to help move the needle in life science.

Big4Bio: What was the biggest surprise so far in going Physical to Digital? 

DF: The shock came when we announced that decision to go virtual with Digital RESI Europe on Friday, March 6th, and within 24 hours we had an additional 100 global investors and strategic partners sign up in support our now Digital Global event. We will have 3x the amount of attendees we were originally projecting.  Digital RESI is a “first-of-its-kind live experiment,” and LSN will soon see if we  can keep the early stage partnering business active by creating some virtual momentum.  LSN needs all the help we can get to see if we can make this event happen.  It is looking great thus far!

Big4Bio: How do the metrics look? 

DF: The metric that has surprised us at LSN is that we will have over 300 investors accepting partnering meetings, judging pitch presentation and participating on panels. We will have 3X the attendees if we were doing a physical RESI Europe Paris.  Every day the numbers keep on going up: this morning, Israel surfaced with multiple registrations with more to come.

Big4Bio: LSN is a small company with around a dozen staff…how are they doing with the transition? 

DF: The feeling among LSN’s amazing staff was that we must adapt and continue to try and move the needle in life science by helping get new technology funded.  The life science industry is unique in that the business models employed today are virtual in nature with small startup teams using global service providers to develop products. Global conferences are a huge part of this virtual ecosystem.  Digital RESI could not come to fruition without LSN staff deciding to go for it and executing on a bunch of levels. LSN has a diverse and dynamic staff, multitalented, multilingual and each person comes with a unique set of skills. Suffice to say, we are small but mighty and LSN has incredible global reach because the LSN staff has developed such long-lasting global relationships over the years.

Big4Bio: Can the life science Execs who attend Physical RESI adapt to a digital model? 

DF: The bigger question is, can the industry adapt and use a virtual conference and partnering platform. LSN has access to all the technology needed to simulate a physical conference with a digital conference, as everyone will see next week. Today everybody is in the same boat. Most of the life science players are home and working remotely so we will see if a digital conference implementation can be helpful.  It is our first one and we cobbled it together in ten days. LSN thinks it will be functional enough, and we will be on the look out to see what worked, what didn’t and what we can improve.

Big4Bio: Is Digital RESI staying cross border and cross domain? 

DF: LSN’s Digital RESI conference is cross-domain and is relevant to early-stage buyers and sellers across the silos of Drugs, Devices, Diagnostics and Digital Health, the “4 Ds”. RESI caters to both the earliest stage startups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding.   Digital RESI will have a global investor presence, and scientist-entrepreneurs and fundraising CEOS form North America, Europe and Asia.

Big4Bio: Can Digital RESI bring the same level of investors and strategic partners? 

DF: Digital RESI will have a lot of the key VC and Big Pharma investors who are seeking new, early stage therapeutics that are big dollar long term bets. The BIG uptick is in the other categories of investors that are signed up, family offices, angels, corporate VC, endowments, foundations, patient groups and private wealth all looking at devices, diagnostics and digital health. The Digital RESI event is a wonderful opportunity for startups from seed-Series B to take advantage of 3 days of partnering to meet with these global investors.

The Incredible Success of Digital Partnering

19 Mar

By Karen Deyo, Senior Investor Research Analyst, LSN

The team at LSN are being consistently blown away by the eager response to bringing RESI and our partnering platform to a virtual system. Investors and companies are taking advantage of the multi-day virtual partnering experience, with 100s of meetings being booked a day over the past few days. Over the past year, I have managed the back-end of RESI partnering, and I am amazed to see the activity on the platform. We anticipate over 800 meetings will take place over the three days of partnering, and that the number of meetings booked will be more than double what we would have seen at a physical RESI conference with the same number of attendees.

The benefit of the digital partnering platform is that it is built on our existing partnering system, allowing companies to easily identify investors and strategic partners who are a fit for them. Attendees can now request, book and participate in meetings from one place. The virtual partnering allows attendees to participate in meetings with multiple colleagues and features a screensharing function as well. Basically, this system combines the features of the video conferencing platforms that we use on a daily basis, without requiring attendees to do more than schedule their meeting as they normally would at RESI.

Carrying on business as usual has been impossible, and the whole world has had to adapt to a new reality over the past few months. The transition from in-person meetings to virtual, while not ideal, is allowing startups to continue their mission of bringing new technologies to the clinic. More than ever, current events are proving how necessary it is to keep moving forward, and as many startups will be facing a difficult time ahead in moving their technologies towards the market, we are appreciative of the support of the investors in LSN’s global ecosystem in adopting this digital format. There is still room for plenty more meetings – it’s not too late to register!

%d bloggers like this: